Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:53:15.550Z.
Calculation as of: 2026-10-06T17:53:15.550Z.
Quote observation: 2026-10-06T17:50:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 79812cd6dc1246c3578cfde2233ee829467ffef9b0062efd9074e0cc555abd58
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Solid Biosciences Inc.
Market Cap
$681.76M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$672.77M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$668.98M
Free Cash Flow Yield
6.07%
TTM Avg
8.57%
3Y Avg
5.30%
5Y Avg
5.30%
Market Cap
$702.28M
Free Cash Flow Yield
N/A
TTM Avg
5.55%
3Y Avg
5.46%
5Y Avg
5.46%
Market Cap
$666.78M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$697.47M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$698.13M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | $681.76M | N/A | N/A | N/A | N/A |
| ArriVent BioPharma, Inc. (AVBP)vs › | $672.77M | N/A | N/A | N/A | N/A |
| Helus Pharma Inc. (HELP)vs › | $668.50M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $668.98M | 6.07% | 8.57% | 5.30% | 5.30% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $702.28M | N/A | 5.55% | 5.46% | 5.46% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $666.78M | N/A | N/A | N/A | N/A |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $697.47M | N/A | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $666.02M | N/A | N/A | N/A | N/A |
| Anteris Technologies Global Corp. (AVR)vs › | $698.13M | N/A | N/A | N/A | N/A |
| Starling Oncology, Inc. (STLN)vs › | $657.39M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
